Calendar GSK plc

Equities

GSK

GB00BN7SWP63

Real-time Estimate Cboe Europe 11:28:50 2024-05-22 EDT 5-day change 1st Jan Change
1,790 GBX +1.96% Intraday chart for GSK plc -1.35% +23.29%

Chart calendar GSK plc

1444185dae8129cc8fce2a.taVqjK3BAEr6FJ9idkgITqANRTZF4wvqnUb-iOsQz8s.1-MC1sP3bSefY9EbPxFnY89vFWJ9oWeJ5Ra8uZFRgq6E1yT-6484Z6hx8A~dcebbe62660f5d8ef5000a74a248f89e

Upcoming events on GSK plc

2024-05-22 Deutsche Bank dbAccess European Champions Conference
2024-06-05 BNP Paribas Exane CEO Conference
2024-07-31 02:00 Q2 2024 Earnings Release
2024-10-30 02:00 Q3 2024 Earnings Release
2025-02-05 02:00 Q4 2024 Earnings Release
2025-04-29 Q1 2025 Earnings Release (Projected)
2025-07-22 Q2 2025 Earnings Release (Projected)
2025-10-28 Q3 2025 Earnings Release (Projected)
2026-02-10 Q4 2025 Earnings Release (Projected)

Past events on GSK plc

Today J.P. Morgan EMEA All Stars Forum
2024-05-20 Berenberg European Conference
2024-05-19 Barclays European Select Conference
2024-05-15 Ex-dividend day for dividende intermédiaire
2024-05-08 09:30 Annual General Meeting
2024-05-01 07:00 Q1 2024 Earnings Call
2024-05-01 02:00 Q1 2024 Earnings Release
2024-04-29 European Society of Clinical Microbiology and Infectious Diseases Meeting
2024-03-26 10:00 BNP Exane Healthcare Conference
2024-03-19 09:00 Investor Meeting - ESG
2024-03-18 Berenberg UK Corporate Conference
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 02819
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 03095
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 01988
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 03157
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 03080
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 00621
2024-03-06 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 01462
2024-03-06 14:51 Retroviruses and Opportunistic Infection Conference - Poster No 03579
2024-03-05 16:30 Retroviruses and Opportunistic Infection Conference - Poster No 01012

Past dividends on GSK plc

2024-05-15 Interim Payment 0.15 GBP
2024-02-21 Final Payment 0.16 GBP
2023-11-15 Interim Payment 0.14 GBP
2023-08-16 Interim Payment 0.14 GBP
2023-05-17 Interim Payment 0.14 GBP
2023-02-22 Final Payment 0.1375 GBP
2022-11-16 Interim Payment 0.1375 GBP
2022-08-17 Interim Payment 0.1625 GBP
2022-07-17 0 GBP
2022-05-18 Interim Payment 0.14 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP
Released
Forecast
Spread
33 754
33 382
1.11%
34 099
34 076
0.07%
34 114
34 029
0.25%
29 324
29 105
0.75%
30 328
29 850
1.6%

31 627

EBITDA
Million GBP
Released
Forecast
Spread
11 968
11 155
7.28%
9 530
10 575
-9.88%
11 330
10 048
12.76%
10 449
9 257
12.88%
11 635
10 203
14.04%

10 562

EBIT
Million GBP
Released
Forecast
Spread
8 972
9 182
-2.29%
8 906
8 955
-0.55%
8 806
8 717
1.02%
8 151
7 952
2.5%
8 786
8 780
0.07%

9 180

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
6 221
5 926
4.97%
6 968
6 763
3.02%
5 442
5 794
-6.07%
5 628
5 548
1.45%
6 064
7 498
-19.12%

7 386

Net income
Million GBP
Released
Forecast
Spread
4 645
4 026
15.38%
5 749
4 894
17.46%
4 385
3 990
9.91%
14 956
6 238
139.74%
4 928
5 481
-10.09%

5 545

EPS
GBP
Released
Forecast
Spread
1,16
1,06
9.69%
1,43
1,21
17.91%
1,08
1,02
6.28%
3,66
1,66
120.52%
1,22
1,38
-11.61%

1,38

Announcement Date05/02/2003/02/2109/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million GBP
Released
Forecast
Spread
9 780
9 145
6.94%
6 929
6 906
0.33%
7 829
7 214
8.52%
7 376
7 101
3.88%
6 951
6 580
5.64%
7 178
6 795
5.63%
8 147
7 727
5.43%
8 052
7 621
5.65%
7 363
7 060
4.3%

7 536


8 563


8 196


7 590


7 865

EBITDA
Million GBP
Released
Forecast
Spread
3 317
2 850
16.4%
2 639
2 138
23.45%
3 561
2 704
31.68%
1 602
1 855
-13.63%
2 732
2 418
12.97%
2 622
2 506
4.64%
3 351
3 072
9.09%
2 930
2 094
39.93%
2 992
2 406
24.36%

2 594


3 095


1 835







EBIT
Million GBP
Released
Forecast
Spread
2 613
2 291
14.06%
2 008
1 740
15.4%
2 605
2 264
15.08%
1 595
1 509
5.7%
2 092
1 930
8.42%
2 170
1 999
8.56%
2 772
2 570
7.88%
1 752
1 836
-4.58%
2 443
2 099
16.38%

2 209


2 810


1 747


2 408


2 487

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
2 598
2 268
14.55%
896
1 243
-27.89%
1 012
1 860
-45.59%
1 626
946
71.97%
1 907
1 529
24.72%
1 987
1 500
32.51%
1 791
2 225
-19.51%
379
1 361
-72.15%
1 355
1 696
-20.11%

1 823


2 493


1 317







Net income
Million GBP
Released
Forecast
Spread
1 802
1 674
7.66%
975
802
21.54%
10 315
1 356
660.76%
1 495
1 151
29.9%
1 490
1 179
26.41%
1 624
1 213
33.86%
1 464
1 739
-15.79%
350
834
-58.04%
1 046
1 297
-19.32%

1 425


1 877


1 214







EPS
GBP
Released
Forecast
Spread
0,45
0,41
8.83%
0,21
0,21
-3.22%
2,52
0,34
640.73%
0,37
0,19
95.19%
0,37
0,29
27.52%
0,40
0,30
35.52%
0,36
0,43
-15.26%
0,09
0,20
-58.02%
0,25
0,31
-19.17%

0,34


0,45


0,29







Announcement Date27/04/2227/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/2401/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW